Trial site
American Heart of Poland S.A.
- 16running trials
- 6closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Heart failure10 trials
- Atrial fibrillation6 trials
- Obesity4 trials
- Coronary artery disease3 trials
- Stroke3 trials
- Type 2 diabetes2 trials
- Chronic kidney disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Phase
- Phase 315 trials
- Phase 27 trials
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Completed5 trials
- Recruiting5 trials
- Not yet recruiting3 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Novo Nordisk A/S4 trials
- Amgen Inc.2 trials
- Anthos Therapeutics, Inc.2 trials
- Hoffmann-La Roche2 trials
- Regeneron Pharmaceuticals2 trials
- and 11 more
Running trials
Not yet recruiting
A study to compare heart failure medicines in one combined pill with usual care.
Recruiting
Recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure
Active, not recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure4 recruiting
- Atrial fibrillation2 recruiting
- Obesity2 recruiting
- Coronary artery disease1 recruiting
- Stroke1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026